This activity is intended for primary care physicians, physician assistants, nurse practitioners, nurses, dietitians, pharmacists and other health care professionals who manage patients with diabetes.
At the end of this activity, the attendees should be able to:
- Discuss the role of recently approved insulin therapies in the treatment of type 2 diabetes
- Discuss the role of recently approved non-insulin injectable and fixed-dose combination injectable therapies in the treatment of type 2 diabetes
- Review the potential benefits and precautions associated with injectable therapy use in type 2 diabetes